However, although decreased expression of PTEN mRNA also correlated with poor OS in patients with NSCLC, its value did not reach statistical significance (HR = 0.60, 95% CI: 0.34–1.07, P = 0.084) (Figure S1, Table 2). This evidence concerns the gene PTEN and non-small cell lung carcinoma.